文献速递浆细胞疾病

如何治疗年轻多发性骨髓瘤患者

How I treat the young patient with multiple myeloma.
PubMed 文献 · Blood · 2018-07-02

本文综述了年轻多发性骨髓瘤患者的治疗策略。新型药物(免疫调节剂、蛋白酶体抑制剂、单克隆抗体)较传统化疗更有效且耐受性更好,已改善生存。治疗可基于宿主与疾病特征个体化,当前标准治疗倾向于在选定患者中可选或延迟自体干细胞移植,并采用诱导缓解后维持治疗的延长治疗策略。

要点

  • 新型药物较传统化疗更有效且耐受性更好,已改善生存。
  • 年轻患者治疗可基于宿主与疾病特征个体化,并采用高灵敏度技术监测残留病。
  • 当前标准治疗包括诱导缓解后维持治疗的延长治疗策略,以及在选定患者中可选或延迟自体干细胞移植。

核心结论

  • 新型药物显著提升了当前标准治疗,治疗范式转向在选定患者中可选或延迟自体干细胞移植作为合理选择。
  • 诱导缓解后维持治疗的延长治疗现为一种标准治疗,在短期和长期均带来更可控的毒性、更长的疾病控制及改善的生活质量。

研究设计与样本

  • 本文为综述,检索范围原文未报告。

主要发现

  • 免疫调节药物、蛋白酶体抑制剂和单克隆抗体较传统化疗更有效且通常耐受性更好,引入临床实践后改善了生存。
  • 对疾病生物学的更好理解、改进的诊断标准以及敏感特异的疾病预后工具的发展促进了更好的结局。
  • 年轻患者的治疗可基于宿主和疾病特征个体化,并加强反应监测和使用高灵敏度技术评估残留病。

临床怎么用

  • 在选定患者中,可选或延迟自体干细胞移植是合理选择。
  • 诱导缓解后维持治疗的延长治疗现为一种标准治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The treatment landscape for multiple myeloma has been transformed by the introduction of novel agents, including immunomodulatory drugs, proteasome inhibitors, and monoclonal antibodies. These have been shown to be more effective and generally better tolerated than conventional chemotherapy, with their introduction into clinical practice leading to improved survival. Furthermore, a better understanding of disease biology, improved diagnostic criteria, and the development of sensitive and specific tools for disease prognostication have contributed to better outcome. Treatment in the younger patient can now be individualized based on host and disease features with enhanced monitoring of response and use of high-sensitivity techniques for evaluating residual disease. The current standard of care has been significantly enhanced by novel agents with a paradigm shift toward optional or delayed autologous stem cell transplant as a reasonable choice in selected patients. Conversely, extended treatment with induction of remission followed by maintenance strategies is now a standard of care, conferring prolonged disease control with more manageable toxicities in both the short and long term, as well as improved quality of life.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Gandolfi S, Prada CP, Richardson PG, et al. How I treat the young patient with multiple myeloma. Blood. 2018. PMID: 29967130. doi:10.1182/blood-2017-05-693606

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。